Pain Medication Not Available and Pain Care Not Addressed
Summary
The facility failed to ensure pain medication was available for administration for two residents, failed to clarify a physician order for a pain medication dose for one resident, and failed to initiate a care plan for pain that had been triggered on the CAA for one resident. These failures affected two of the three residents reviewed for pain and included one resident receiving hospice comfort-focused care and another resident with chronic back pain and moderate cognitive impairment. One resident was admitted to the facility by ambulance and had a hospice diagnosis of end stage heart failure. The resident had a physician order for Morphine Sulfate concentrate, 10 mg sublingually every hour as needed for pain and/or air hunger, but the July MAR documented no morphine administration on the day of admission. The MAR also included pain monitoring every shift, but no pain monitoring was documented that day. The first documented morphine dose was given about 26 hours after admission. A nursing note documented that the resident’s family requested as-needed pain medication and staff were unable to locate it, and follow-up with hospice and the pharmacy showed the prescriptions had not been received and were pending clarification regarding which pharmacy was to receive the orders. Pharmacy staff later stated the order received did not include morphine. A CNA also observed the resident appearing uncomfortable during repositioning, with grunting on movement. The second resident had diagnoses including lumbar intervertebral disc degeneration with discogenic back pain, functional quadriplegia, muscle wasting and atrophy, and abnormal posture. The resident’s MDS documented moderate cognitive impairment and occasional moderate-severe pain, and the CAA identified pain as a problem to be carried over to the care plan. However, the current care plan did not include a pain category or interventions to direct staff on pain relief. The physician order for Lidocaine External Patch listed application to the affected area once daily for mild pain, but no dose was identified. The MAR and nursing notes showed the Lidocaine patch was not administered for several consecutive days because the facility was out of stock, with one date signed as given in error. During interview, the resident stated the patch had not been applied for several days, that the resident had never refused it, and that without the patch the back pain increased to 7 to 8 out of 10 and interfered with sleep. The resident reported that Tylenol lowered the pain somewhat, but the patch maintained pain at about 2 out of 10. The resident’s family member stated the resident had pain all the time and that the Lidocaine patches helped take the edge off.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.